baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Ionis Pharmaceuticals/ US4622221004 /

4/25/2025 9:59:58 PM	Chg. +0.15	Volume	Bid9:59:59 PM	Ask9:59:58 PM	High	Low
29.69USD	+0.51%	71,575 Turnover: 2.12 mill.	29.68Bid Size: 100	29.71Ask Size: 100	29.90	28.78

GlobeNewswire 4/2 Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the T...

GlobeNewswire 3/24 Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders ...

GlobeNewswire 2/28 Praxis Precision Medicines Provides Update on Essential3 and Corporate Update

GlobeNewswire 2/26 Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024

GlobeNewswire 8/13/2024 Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Resul...

Newsfile Corp 7/17/2024 Analysts Hunt for Undervalued Biotech Stocks

GlobeNewswire 5/30/2024 Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...

GlobeNewswire 5/16/2024 Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...

GlobeNewswire 5/13/2024 Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Result...

GlobeNewswire 5/7/2024 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference

GlobeNewswire 4/23/2024 ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held M...

GlobeNewswire 4/22/2024 Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...

GlobeNewswire 3/6/2024 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...

GlobeNewswire 3/5/2024 Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...

GlobeNewswire 2/23/2024 Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positiv...

GlobeNewswire 1/8/2024 Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio

TeleTrader 12/22/2023 US FDA approves AstraZeneca-Ionis's medicine

GlobeNewswire 3/28/2022 Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotroph...

GlobeNewswire 3/17/2022 Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors

GlobeNewswire 3/14/2022 Biogen Announces New Updates Across its SMA Research Program at 2022 MDA Conference

GlobeNewswire 3/9/2022 Antisense Therapeutics to present poster at world’s largest NMD conference

GlobeNewswire 2/24/2022 ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results

GlobeNewswire 2/2/2022 n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare D...

GlobeNewswire 1/4/2022 Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA

GlobeNewswire 1/3/2022 Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer

Ionis Pharmaceuticals/ US4622221004 /

If you wish to receive reply to your feedback, please provide your email address.